Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism

Blood (2018) 132 (Supplement 1): 2527.

https://doi.org/10.1182/blood-2018-99-113589

Published: 2018

Journal Articles

Recurrent Venous Thromboembolism during Anticoagulation: An Investigator-Initiated Post-Hoc Analysis of the Hokusai-VTE Trial

Sabine Eichinger, MD, Min Lin, PhD, Paul A. Kyrle, MD, Michael A. Grosso, MD

Blood (2018) 132 (Supplement 1): 2539.

https://doi.org/10.1182/blood-2018-99-118093

Published: 2018

Journal Articles

Effects of Chemotherapy on Extracellular Vesicles and Coagulation Activation in Colorectal Cancer Patients: A Pilot Study

Ludwig Traby, MD, Hannah C. Puhr, Marietta Kollars, Kammer Michael, Gerald Prager, MD, Werner Scheithauer, MD, Gabriela Kornek, MD, Paul Alexander Kyrle, MD, Sabine Eichinger, MD

Blood (2016) 128 (22): 1425.

https://doi.org/10.1182/blood.V128.22.1425.1425

Published: 2016

Journal Articles

the Long-Term Recurrence Risk of Patients with Unprovoked Venous Thromboembolism: An Observational Cohort Study

Paul A Kyrle, MD, Michael Kammer, Lisbeth Eischer, Georg Heinze, Sabine Eichinger, MD

Blood (2016) 128 (22): 273.

https://doi.org/10.1182/blood.V128.22.273.273

Published: 2016

Journal Articles

Risk of Cancer after Long-Term Anticoagulation in Patients with Unprovoked Venous Thromboembolism

Sabine Eichinger, MD, Paul Alexander Kyrle, Michael Kammer, Lisbeth Eischer

Blood (2015) 126 (23): 3545.

https://doi.org/10.1182/blood.V126.23.3545.3545

Published: 2015

Journal Articles

Naturally Occurring Autoantibodies to Oxidation-Specific Epitopes in Patients with Venous Thromboembolism

Sabine Eichinger, MD, Paul A Kyrle, MD, Michael Kammer, MSc, Lisbeth Eischer, MD, Christoph Binder, MD

Blood (2014) 124 (21): 2861.

https://doi.org/10.1182/blood.V124.21.2861.2861

Published: 2014

Journal Articles

D-Dimer Levels Over Time and The Risk Of Recurrent Venous Thromboembolism: An Update Of The Vienna Prediction Model

Sabine Eichinger, MD, Georg Heinze, Paul A Kyrle, MD

Blood (2013) 122 (21): 462.

https://doi.org/10.1182/blood.V122.21.462.462

Published: 2013

Journal Articles

The Risk Of Recurrence In Women With Venous Thromboembolism While Using Estrogens: A Prospective Observational Cohort Study

Paul A Kyrle, MD, Lisbeth Eischer, MD, Sabine Eichinger, MD

Blood (2013) 122 (21): 1123.

https://doi.org/10.1182/blood.V122.21.1123.1123

Published: 2013

Journal Articles

Aspirin After Oral Anticoagulants for Prevention of Recurrence in Patients with Unprovoked Venous Thromboembolism. the Warfasa STUDY

Blood (2011) 118 (21): 543.

https://doi.org/10.1182/blood.V118.21.543.543

Published: 2011

Journal Articles

Hypofibrinolysis and the Risk of Recurrent Venous Thromboembolism: A Prospective Cohort Study,

Sabine Eichinger, MD, Ludwig Traby, MD, Georg Heinze, Marietta Kollars, Lisbeth Eischer, Paul Alexander Kyrle, MD

Blood (2011) 118 (21): 3331.

https://doi.org/10.1182/blood.V118.21.3331.3331

Published: 2011

Journal Articles

Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score

Alberto Tosetto, M.D., Alfonso Iorio, Maura Marcucci, Trevor Baglin, MD, Mary Cushman, MD, MSc, Sabine Eichinger, MD, Gualtiero Palareti, Daniela Poli, MD, Campbell R Tait, James D. Douketis, MD

Blood (2011) 118 (21): 544.

https://doi.org/10.1182/blood.V118.21.544.544

Published: 2011

Journal Articles

Hematocrit and the Risk of Recurrent Venous Thrombosis: a Prospective Cohort Study

Lisbeth Eischer, MD, Verena Tscholl, MD, Georg Heinze, PhD, Ludwig Traby, MD, Paul Alexander Kyrle, MD, Sabine Eichinger, MD

Blood (2010) 116 (21): 807.

https://doi.org/10.1182/blood.V116.21.807.807

Published: 2010

Journal Articles

Effects of Recombinant Factor VIIa (NovoSeven®) on Restoring Thrombin Generation in Patients with Hemophilia A and Antibodies to Factor VIII.

Sabine Eichinger, MD, Barbara Lubszcyk, MD, Karl Zwiauer, MD, Andreas Gleiss, PhD, Peter Quehenberger, MD, Paul Alexander Kyrle, MD

Blood (2007) 110 (11): 1161.

https://doi.org/10.1182/blood.V110.11.1161.1161

Published: 2007

Journal Articles

Endothelial Cell-Derived Microparticles in the Pathogenesis of Chemotherapy-Associated Hypercoagulability.

Daniel Lechner, MD, Marietta Kollars, Sabine Eichinger, MD, Paul Alexander Kyrle, MD, Ansgar Weltermann, MD

Blood (2006) 108 (11): 1457.

https://doi.org/10.1182/blood.V108.11.1457.1457

Published: 2006

Journal Articles

Risk of Recurrent Venous Thromboembolism Reduced by High Density Lipoproteins.

Sabine Eichinger, MD, Natalie M. Pecheniuk, Ph.D., Gregor Hron, M.D., Hiroshi Deguchi, M.D., Ph.D., Paul A. Kyrle, M.D., John H. Griffin, Ph.D.

Blood (2006) 108 (11): 271.

https://doi.org/10.1182/blood.V108.11.271.271

Published: 2006

Journal Articles

Homozygosity in the Single Nucleotide Polymorphism Ser128Arg in the E-Selectin Gene Is Associated with Recurrent Venous Thromboembolism.

Gregor Hron, MD, Bernd Jilma, MD, Claudia L. Marsik, MD, Georg Endler, MD, Sabine Eichinger, MD, Paul Alexander Kyrle, MD

Blood (2006) 108 (11): 4086.

https://doi.org/10.1182/blood.V108.11.4086.4086

Published: 2006

Journal Articles

Microparticles Are a Major Determinant of Thrombin Generation Measured by Technothrombin®TGA.

Viktoria Kaufmann, BS, Jutta Mager, Sabine Eichinger, MD, Bernd R. Binder, MD

Blood (2006) 108 (11): 1462.

https://doi.org/10.1182/blood.V108.11.1462.1462

Published: 2006

Journal Articles

Endogenous Thrombin Potential (ETP) for Assessing the Risk of Recurrent Venous Thromboembolism.

Sabine Eichinger, MD, Gregor Hron, MD, Ansgar Weltermann, MD, Marietta Kollars, Paul A. Kyrle, MD

Blood (2005) 106 (11): 1622.

https://doi.org/10.1182/blood.V106.11.1622.1622

Published: 2005

Journal Articles

The Association between Tissue Factor-Exposing Microparticles and the Activation of the Coagulation System in Cancer Patients.

Ansgar Weltermann, MD, Gregor Hron, PD, Marietta Kollars, Gabriela Kornek, MD, Peter Quehenberger, MD, Sabine Eichinger, MD, Paul Alexander Kyrle, MD

Blood (2004) 104 (11): 2589.

https://doi.org/10.1182/blood.V104.11.2589.2589

Published: 2004

Journal Articles

Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A First Randomised, Placebo-Controlled, Double-Blind Trial.

Gerard M.J. Bos, MD, PhD, Martin Heijer den, MD, PhD, Huub Willems, MD, Henk Blom, PhD, Wim Gerrits, MD, Marco Cattaneo, MD, Sabine Eichinger, MD, Frits Rosendaal, MD

Blood (2004) 104 (11): 489.

https://doi.org/10.1182/blood.V104.11.489.489

Published: 2004

NARROW

Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism

Recurrent Venous Thromboembolism during Anticoagulation: An Investigator-Initiated Post-Hoc Analysis of the Hokusai-VTE Trial

Effects of Chemotherapy on Extracellular Vesicles and Coagulation Activation in Colorectal Cancer Patients: A Pilot Study

the Long-Term Recurrence Risk of Patients with Unprovoked Venous Thromboembolism: An Observational Cohort Study

Risk of Cancer after Long-Term Anticoagulation in Patients with Unprovoked Venous Thromboembolism

Naturally Occurring Autoantibodies to Oxidation-Specific Epitopes in Patients with Venous Thromboembolism

D-Dimer Levels Over Time and The Risk Of Recurrent Venous Thromboembolism: An Update Of The Vienna Prediction Model

The Risk Of Recurrence In Women With Venous Thromboembolism While Using Estrogens: A Prospective Observational Cohort Study

Aspirin After Oral Anticoagulants for Prevention of Recurrence in Patients with Unprovoked Venous Thromboembolism. the Warfasa STUDY

Hypofibrinolysis and the Risk of Recurrent Venous Thromboembolism: A Prospective Cohort Study,

Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score

Hematocrit and the Risk of Recurrent Venous Thrombosis: a Prospective Cohort Study

Effects of Recombinant Factor VIIa (NovoSeven®) on Restoring Thrombin Generation in Patients with Hemophilia A and Antibodies to Factor VIII.

Endothelial Cell-Derived Microparticles in the Pathogenesis of Chemotherapy-Associated Hypercoagulability.

Risk of Recurrent Venous Thromboembolism Reduced by High Density Lipoproteins.

Homozygosity in the Single Nucleotide Polymorphism Ser128Arg in the E-Selectin Gene Is Associated with Recurrent Venous Thromboembolism.

Microparticles Are a Major Determinant of Thrombin Generation Measured by Technothrombin®TGA.

Endogenous Thrombin Potential (ETP) for Assessing the Risk of Recurrent Venous Thromboembolism.

The Association between Tissue Factor-Exposing Microparticles and the Activation of the Coagulation System in Cancer Patients.

Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A First Randomised, Placebo-Controlled, Double-Blind Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only